CDP840. A prototype of a novel class of orally active anti-Inflammatory phosphodiesterase 4 inhibitors

Rakki P. Alexander(Cell Technology (China)), G.A. Higgs, David M. Barnes, Graham J. Warrellow, J. C. Leonard, B. Mason, Brian Hutchinson(Joint Global Change Research Institute), Julien A. Brown, Richard Morphy, Byron A. Boyce, EileenA. Boyd, Rodger A. Allen(Scripps Research Institute), Maria de Jesus Perry, Martin R. Wales, Paul Turner(Yale University), Neil Gozzard, Andrew T. Millican, James Reuberson, John C. Head, JC Porter, B. Hughes, Michael A. W. Eaton(Science Applications International Corporation (United States)), A. Cannell, Russell J. Taylor, Albert Y. Zomaya(Centre for High Performance Computing)
Bioorganic & Medicinal Chemistry Letters
June 1, 2002
Cited by 57


Related Papers